Further, the available biomarkers such as CA 125 for ovarian cancer, CA 19-9 for pancreatic cancer and CEA (carcino embryonic antigen) for colon cancer have poor sensitivity and specificity. The gene discussed is CEACAM5; the disease is malignant colon neoplasm.